Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new sophistication. The management of chronic pain in general is now being broadly ...

Right now, the FDA has approved the new drug to treat pain from an injury or surgery. Its manufacturer is also testing it for ...

Mission Viejo's neurosurgeon explores spinal cord stimulation as a promising alternative for chronic back pain relief, focusing on innovative treatments. MISSION VIEJO, CALIFORNIA / ACCESS Newswire / ...

Mission Viejo's neurosurgeon explores spinal cord stimulation as a promising alternative for chronic back pain relief, ...

(THE CONVERSATION) Chronic pain affects hundreds of millions of people around the world. But the opioid crisis in North America led many health care providers to realize they relied too heavily on ...

GlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.

Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...

The collaboration with Limitless Guided Visualizations introduces a blend of neurological treatments and guided mindset ...

Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty ...

"Neuromodulation using gene therapy is an exciting new area that has wide-spread applications in treating not only chronic pain but other serious undertreated neurological disorders. We are delighted ...